- Fraudulent Email Warning（27KB）
News Release
- January 5, 2026
- President’s Greetings for 2026 (375KB)
- December 24, 2025
- Notice Regarding the Establishment of a Subsidiary (117KB)
- December 15, 2025
- Notice of Subsidiary Name Change and Transfer of Sales Organization of Vascular Division (310KB)
IR News
- December 9, 2025
- The 73rd Interim Shareholders’ Newsletter
- November 21, 2025
- Toward NIPRO's Sustainable Growth
- November 10, 2025
- Consolidated Financial Results for the Six Months Ended September 30, 2025 [Japanese GAAP] / Notice Regarding Difference between Consolidated Financial Forecasts and Actual Results for the Six Months Ended September 30, 2025 / IR Materials
Our Business
Meeting the needs of front line medical treatment with unique products and technologies
To meet the needs of the front line of medical treatment, NIPRO creates unique products at its four research and development sites while leveraging the technologies cultivated in its various businesses.
Mission, Vision, Value
We will work as a truly global comprehensive medical manufacturer with a willingness to consider patient and user viewpoints.
